Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T05:32:38.318Z Has data issue: false hasContentIssue false
  • English
  • Français

RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)

Published online by Cambridge University Press:  30 October 2014

B. Fisher ,
C. Hu ,
D. Macdonald ,
G. Lesser ,
S. Coons ,
D. Brachman ,
S. Ryu ,
M. Werner-Wasik ,
J.P. Bahary  and
A. Chakravarti
...Show all authors
B. Fisher
Affiliation:
Western University, London, Ontario
C. Hu
Affiliation:
Radiation Therapy Oncology Group, Philadelphia
D. Macdonald
Affiliation:
Western University, London, Ontario
G. Lesser
Affiliation:
Wake Forrest University, Winston-Salem
S. Coons
Affiliation:
Barrow Neurological Institute, Pheonix
D. Brachman
Affiliation:
Arizona Oncology Services Foundation, Pheonix
S. Ryu
Affiliation:
Henry Ford Hospital, Detroit
M. Werner-Wasik
Affiliation:
Thomas Jefferson University Hospital, Philadelphia
J.P. Bahary
Affiliation:
Centre Hospitalier de l'Universite de Montreal, Montreal
A. Chakravarti
Affiliation:
The Ohio State University, The James
M. Mehta
Affiliation:
University of Maryland Medical Systems, Baltimore
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical Oral Presentations 14 June 2014
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue s2: 16th Biennial Canadian Neuro-Oncology Meeting , October 2014 , pp. S7
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2014